Hip Osteoarthritis Clinical Trial
Official title:
Psychosocial Interventions for Young Adults With Hip Pain
Psychosocial conditions are common in young adults with hip pain including depression, anxiety, pain catastrophizing, and narcotic use. The incidence of these conditions is not well defined. Interventions to optimize psychosocial conditions with non-surgical or surgical treatments has not been investigated. The goal of this project is to determine the incidence of psychosocial conditions in the young adult population with hip pain and determine if cognitive based therapy can improve clinical outcomes in these individuals.
Status | Not yet recruiting |
Enrollment | 150 |
Est. completion date | August 1, 2025 |
Est. primary completion date | August 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 39 Years |
Eligibility | Inclusion Criteria: - We will enroll young adults (15-39) presenting to one of several physical therapy and orthopedic practices in the state of Iowa for treatment of nonarthritic hip pain. - Chief complaint of hip pain or dysfunction, and a diagnosis of a nonarthritic hip condition including labral tear, femoroacetabular impingement (FAI), snapping hip, femoral anteversion or dysplasia. Exclusion Criteria: - Exclusion criteria will include age <15 or >40 years - Difficulty with written English - Treatment for alternative conditions such as trochanteric bursitis, hip dislocation, avascular necrosis or fracture. |
Country | Name | City | State |
---|---|---|---|
United States | University of Iowa | Iowa City | Iowa |
Lead Sponsor | Collaborator |
---|---|
Michael C Willey |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in level of Depression (DASS-21) | Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire
General adult population average total score: 9.43 (standard deviation (SD) 9.66), out of a total possible score of 63 points, Indication of significant difference from normative data: Average score >1 SD above the General adult population average total score General adult population average depression sub scale score: 2.83 (SD 3.87) Values above 9.03 points in the depression subsection score correlate with clinical depression and generalized anxiety disorders A change of 3.86 or more points in the depression subscore reliably represents clinical improvement. |
8 weeks | |
Primary | Changes in level of Depression (PROMIS) | Assessed using the Patient Reported Outcome Measures Information (PROMIS): Depression. An electronically administered patient reported outcome questionnaire
Normative T-score generated from US adult population data: mean 50 (SD 10). For this study, an average T-score <40 would be considered significantly different compared to normative values. The minimally important difference (MID) of 3.0-3.1 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks. |
8 weeks | |
Primary | Changes in level of Anxiety (DASS-21) | Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire
General adult population average total score: 9.43 (SD 9.66) An average total score >1 SD above the mean would be considered significantly different from normative data General adult population average anxiety subscale scores: 1.88±2.95 Average anxiety subsection score above 6.27 correlate with clinical depression and generalized anxiety disorders A change of 3.85 or more points in the anxiety subscore reliably represents clinical improvement. |
8 weeks | |
Primary | Changes in level of Anxiety (PROMIS) | Assessed using the Patient Reported Outcome Measures Information (PROMIS): Anxiety. An electronically administered patient reported outcome questionnaire
Normative T-score generated from US adult population data: mean 50 (SD 10). For this study, an average T-score <40 would be considered significantly different compared to normative values. The minimally important difference (MID) of 2.3 to 3.4 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks. |
8 weeks | |
Primary | Changes in level of Stress (DAAS-21) | Assessed using the Depression Anxiety Stress Scale (DASS-21) electronically administered patient reported outcome questionnaire
General adult population average total score: 9.43 (SD 9.66) An average total score >1 SD above the mean would be considered significantly different from normative data General adult population average stress subscale scores: 4.73±4.20 Average stress subsection score above 12.27 correlate with clinical depression and generalized anxiety disorders A change of 4.90 or more points in the anxiety subscore reliably represents clinical improvement. |
8 Weeks | |
Primary | Evaluating the presence and severity of Kinesiophobia | Assessed via the Shortened Tampa Scale for Kinesiophobia (TSK-11) electronically administered patient reported outcome questionnaire
The survey is a 11-question test scored from 11-44, where higher scores indicate increasing fear of movement. A value of 11 is presumed in a nonpainful population. Adults with chronic musculoskeletal pain undergoing outpatient chronic pain therapy report an average TSK score of 30.4 (+/- 6.6). Successful evaluation of Kinesiophobia will be indicated if increases in TSK-11 scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding. |
8 weeks | |
Primary | Evaluation of Resiliency | Assessed via The Brief Resiliency Scale (BRS) electronically administered patient reported outcome questionnaire
An 8 question survey scored from 1-5 points The average score for US adults age 24-34 is 3.2 (SD 0.7) A statistically significant lower Grit score would be >1SD below this average value. Successful evaluation of Grit will be indicated if increases in GRIT-S scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding. |
8 weeks | |
Primary | Evaluation of Grit | Assessed via The Short Grit Scale (GRIT-S) electronically administered patient reported outcome questionnaire
A 6-question test with low resiliency defined as a score of <3.00. Prior descriptive studies indicate an average score of 3.57 (SD 0.76) for young adults age 19.8±3.0 years. Statistically significant lower resilience would be >1SD below this average value. Successful evaluation of Resiliency will be indicated if increases in GRIT-S scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents (for those tests where this data exists) would also be considered a successful finding. |
8 weeks | |
Primary | Evaluating the presence and severity of Pain Catastrophizing | Assessed via Pain Catastrophizing Scale (PCS) electronically administered patient reported outcome questionnaire
Scored on a 13 point scale. Normative average values from a population of adults adults age 42.2 (17-63 years) with low back pain: mean 20.90 (SD 12.5), Successful evaluation of Pain Catastrophization will be indicated if increases in PCS scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding. |
8 weeks | |
Primary | Evaluating Self-Efficacy | Assessed via The General Self-Efficacy Scale (GSE) electronically administered patient reported outcome questionnaire
10-question test, scored from 10-40, with lower scores representing low self efficacy. Average US adult values: 29.48 (SD 5.13) Successful evaluation of Self-Efficacy will be indicated if increases in GSE scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding. |
8 weeks | |
Primary | Evaluating the presence and severity of Alcohol Use Disorders | Assessed via Alcohol Use Disorders Identification Test (AUDIT) electronically administered patient reported outcome questionnaire
A 10-question test with a threshold score >7 considered "AUDIT-positive", indicating risky or hazardous alcohol use behavior. National data suggests 15-20% of US 14-18 year olds screen positive Successful evaluation of Alcohol Use Disorders will be indicated if increases in AUDIT scores are found to be significantly associated with increased pain and decreased physical function (HOOS, PROMIS-PI, PROMIS-PB, PROMIS-PF) or increased self-reporting of opioid use. The finding of no significant association, but increased presence of maladaptive features compared to normative data for US adolescents would also be considered a successful finding. |
8 weeks | |
Primary | Changes in Physical Function (PROMIS) | Measured via the following electronically administered patient reported outcome questionnaires.
PROMIS: Physical Function (PF) Normative T-score generated from US adult population data: mean 50 (SD 10). For this study, an average T-score <40 would be considered significantly different compared to normative values. The minimally important difference (MID) of 1.9 - 2.2 calculated from research in nonoperative treatment of knee osteoarthritis will be representative of clinical improvement at eight weeks. |
8 weeks | |
Primary | Changes in Physical Function (HOOS) | Measured via the following electronically administered patient reported outcome questionnaires.
The Hip disability and osteoarthritis outcome score (HOOS) Scored from 0-100 Increasing score represent better function. Average scopres for hip preservation patients prior to surgery is well established |
8 weeks | |
Primary | Reduced Opioid Use | Measured via self reported opioid use after surgery | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03326804 -
H1 Hip Resurfacing Arthroplasty
|
||
Not yet recruiting |
NCT04257682 -
Regional Anesthesia in Total Hip and Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT02876120 -
The STavanger osteoARThritis Study
|
N/A | |
Terminated |
NCT02231567 -
Neurocognitive Rehabilitation After Hip Replacement
|
N/A | |
Recruiting |
NCT02174965 -
Wear and Migration in the Corin Mini-Hip/Metafix and ECIMA Polyethylene
|
N/A | |
Completed |
NCT01506024 -
Minimal Invasive Surgery in Total Hip Arthroplasty Patients; Short- and Long Term Results
|
N/A | |
Active, not recruiting |
NCT04070027 -
Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis
|
N/A | |
Withdrawn |
NCT04421196 -
Opioid-free Total Hip Arthroplasty
|
N/A | |
Not yet recruiting |
NCT05960903 -
Patient Satisfaction After Primary THA In Assiut University
|
||
Completed |
NCT04084704 -
A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis
|
N/A | |
Not yet recruiting |
NCT04018690 -
Project Arthritis Recovering Quality of Life Through Education - Hip
|
N/A | |
Completed |
NCT03648060 -
Efficacy of a Digital Biofeedback System for Home-based Rehabilitation After Total Joint Replacement
|
N/A | |
Recruiting |
NCT05497349 -
Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis
|
N/A | |
Active, not recruiting |
NCT04879732 -
RSA - ACTIS Hip Stem
|
N/A | |
Active, not recruiting |
NCT05142462 -
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
|
||
Recruiting |
NCT04665908 -
PT-led Triage for Patients With Hip o Knee Osteoarthritis
|
N/A | |
Completed |
NCT04648956 -
Arabic Version of the ICOAP Questionnaire
|
||
Recruiting |
NCT05465096 -
Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.
|
N/A | |
Completed |
NCT02884531 -
Patient Education and Basic Body Awareness Therapy in Hip Osteoarthritis: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT03031314 -
Comparison of Knotless Barbed Suture and Standard Suture in Knee Replacement Patients
|
N/A |